CORE Biomedicine
Developing the next generation of precision medicines by going beyond genomics.
$21MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Developing the next generation of precision medicines by going beyond genomics.
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options
Pitching Mitsubishi UFJ Capital Co? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room